Fluorescence-guided resection of primary and recurrent malignant gliomas with 5-aminolevulinic acid. preliminary results;Wycięcie pierwotnych złooeliwych glejaków mózgu oraz ich wznów pod controlą fluorescencji z zastosowaniem kwasu 5-aminolewulinowego. wyniki wstępne

Neurologia i Neurochirurgia Polska

Volumn 46, Issue 1, 2012, Pages 47-51

  Tykocki, Tomasz ^a   Michalik, Radosław ^b   Bonicki, Wiesław ^b   Nauman, Paweł ^a  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Fluorescence; Malignant gliomas; Resection

Indexed keywords

AMINOLEVULINIC ACID;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; KARNOFSKY PERFORMANCE STATUS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY TUMOR; RECURRENT CANCER;

EID: 84858835254     PISSN: 00283843     EISSN: 18974260     Source Type: Journal    
DOI: 10.5114/ninp.2012.27212     Document Type: Article

References (11)

1. Stupp R., Mason W.P., van den Bent M.J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987-996.
2. Lacroix M., Abi-Said D., Fourney D.R., et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001; 95: 190-198.
3. Laws E.R., Parney I.F., Huang W., et al. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 2003; 99: 467-473.
4. Stummer W., Novotny A., Stepp H., et al. Fluorescence-guided resection of glioblastoma multiforme by using 5-r resection of malignant glioma: a randomised controlled multicentre phase III trial; ALA-Glioma Study Group. Lancet Oncol 2006; 7: 392-401.
5. Stummer W., Pichlmeier U., Meinel T., et al. Fluorescenceguided surgery with 5-aminolevulinic acid foyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid. J Photochem Photobiol B 1998; 45: 160-169.
6. Nabavi A., Thurm H., Zountsas B., et al. Five-aminolevulinic acid for fluorescence-guided resection of recurrent malignant gliomas: a phase II study. Neurosurgery 2009; 65: 1070-1076.
7. Stummer W., Novotny A., Stepp H., et al. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 2000; 93: 1003-1013.
8. Jaffe E.K., Shanmugam D., Gardberg A., et al. Crystal structure of Toxoplasma gondii porphobilinogen synthase: insights on octameric structure and porphobilinogen formation. J Biol Chem 2011; 286: 15298-15307.
9. Dhawan S., Weeks B.S., Soderland C., et al. HIV-1 infection alters monocyte interactions with human microvascular endothelial cells. J Immunol 1995; 154: 422-432.
10. Stummer W., Tonn J.C., Mehdorn H.M., et al. Counterba - lancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. J Neurosurg 2010; 114: 613-623.
11. Senft C., Bink A., Heckelmann M., et al. Glioma extent of resection and ultra-low-field iMRI: interim analysis of a pros - pective randomized trial. Acta Neurochir Suppl 2011; 109: 49-53.